18F-FDG PET-Detected Synchronous Primary Neoplasms in the Staging of Esophageal Cancer

Abstract

F-FDG uptake concerning for synchronous neoplasms is evident in approximately 1 in 10 cases, and of these a minority will represent a malignant neoplasm that significantly impacts on treatment. The overall added costs per patient are relatively modest and the treatment delay within acceptable limits of clinical practice.